What We're Reading: Page 39
Industry reads hand-picked by our editors
Aug 07, 2024
Aug 06, 2024
Aug 05, 2024
-
The Wall Street Journal
Ecstasy Drug Trials Missed Suicidal Thoughts of Subjects
-
Reuters
Mallinckrodt to sell Therakos unit to CVC Capital for $925 mln
-
FirstWord Pharma
BioNTech’s Q2 losses quadruple as it banks on cancer-focused future
Aug 02, 2024
Aug 01, 2024
Jul 31, 2024
Jul 30, 2024
-
CNN
Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial
-
MIT Technology Review
Controversial CRISPR scientist promises “no more gene-edited babies” until society comes around
-
C&EN
The future of science publishing
-
NPR
Ozempic’s biggest side effect: Turning Denmark into a ‘pharmastate’?
Previous
